The Anticancer Natural Product Pironetin Selectively Targets Lys352 of α-Tubulin
Open Access
- 30 June 2004
- journal article
- research article
- Published by Elsevier
- Vol. 11 (6) , 799-806
- https://doi.org/10.1016/j.chembiol.2004.03.028
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
- RIKEN
This publication has 34 references indexed in Scilit:
- Refined structure of αβ-tubulin at 3.5 Å resolution 1 1Edited by I. A. WilsonJournal of Molecular Biology, 2001
- The predicted β12-β13 loop is important for inhibition of PP2Acα by the antitumor drug fostriecinFEBS Letters, 2001
- Structural Basis for the Interaction of Tubulin with Proteins and Drugs that Affect Microtubule DynamicsAnnual Review of Cell and Developmental Biology, 2000
- The interaction of the B-ring of colchicine with α-tubulin: a novel footprinting approach 1 1Edited by M. F. MoodyJournal of Molecular Biology, 2000
- Structural Insights into Microtubule FunctionAnnual Review of Biochemistry, 2000
- Apoptosis induction via microtubule disassembly by an antitumour compound, pironetinBiochemical Journal, 1999
- Double mutation in Eleusine indica alpha-tubulin increases the resistance of transgenic maize calli to dinitroaniline and phosphorothioamidate herbicidesThe Plant Journal, 1999
- RK‐682, a potent inhibitor of tyrosine phosphatase, arrested the mammalian cell cycle progression at G1phaseFEBS Letters, 1995
- TCP1 complex is a molecular chaperone in tubulin biogenesisNature, 1992
- Missense mutations at lysine 350 in beta 2-tubulin confer altered sensitivity to microtubule inhibitors in Chlamydomonas.Plant Cell, 1990